Explanation of Program (PDF) Vantage Health Plan is actively engaged in supporting the health and well-being of all of our commercial group employees through a strong wellness program, which focuses on specific health topics, as well as general wellness and prevention services.
After final dilution, protection from light is not required. Oxaliplatin Injection, USP is incompatible in solution with alkaline medications or media (such as basic solutions of 5-fluorouracil) and must not be mixed with these or administered simultaneously through the same infusion line. The infusion line should be flushed with 5% Dextrose Injection, USP prior to administration of any concomitant
addition of oxaliplatin 85 mg/m2 on day 1 only, given as a 2-hour infusion in 250 mL of dextrose 5%, concurrent with LV. Oxaliplatin must not be mixed with normal saline; therefore, when LV and oxaliplatin were given concurrently via a Y-connector, both drugs were administered in 5% dextrose. Routine antiemetic prophylaxis with a 5-hydroxytryptamine-3âreceptor antagonist was used for FOLFOX4 but was not necessary for LV5FU2. The use of implantable ports and